Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Patterson Joshua F. | General Counsel | 9 | $0 | $13.0K | 2020-10-12 |
| Howarth Alex G. | Chief Operating Officer | 7 | $0 | $0 | 2020-10-12 |
| Jenne Kyle | Chief Commercial Officer | 12 | $0 | $22.2K | 2020-10-12 |
| McDevitt Damien | Interim Chief Executive Office | 13 | $0 | $268.5K | 2020-10-12 |
| Hochberg Elaine | Director | 5 | $0 | $0 | 2020-10-12 |
| YANG MICHAEL J. | Director | 3 | $0 | $0 | 2020-10-12 |
| Salzman Amber | Director | 4 | $0 | $0 | 2020-10-12 |
| Andrews William T. | Chief Medical Officer | 4 | $0 | $0 | 2020-10-12 |
| Yanni Barbara | Director | 3 | $0 | $0 | 2020-10-12 |
| PRICE MICHAEL DENNIS | Chief Financial Officer | 4 | $0 | $0 | 2020-10-12 |
| SMITH SANDFORD D | Director | 5 | $0 | $0 | 2020-10-12 |
| KLEIN JOSEPH III | Director | 3 | $0 | $0 | 2020-10-12 |
| PARSHALL B LYNNE | Director | 5 | $0 | $0 | 2020-10-12 |
| IONIS PHARMACEUTICALS INC | 10% Owner | 11 | $610.46M | $0 | 2020-10-10 |
| O'Dea Louis | Chief Medical Officer | 8 | $0 | $37.6K | 2020-03-23 |
| MacLean Michael F | Chief Financial Officer | 6 | $0 | $0 | 2020-01-15 |
| Goldberg Jeff Marc | Chief Operating Officer | 22 | $0 | $1.59M | 2019-09-26 |
| Soteropoulos Paula | President & CEO | 20 | $0 | $1.61M | 2019-09-26 |
| Boyce Sarah | President | 5 | $0 | $42.8K | 2019-07-15 |
| FITZGERALD EDWARD M | Director | 2 | $0 | $0 | 2019-06-14 |
| GABRIELI CHRISTOPHER | Director | 2 | $0 | $0 | 2019-06-14 |
| MOSCICKI RICHARD A | Director | 3 | $0 | $0 | 2019-06-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| PARSHALL B LYNNE | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| Hochberg Elaine | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 52,837 | $5.94 | $313.9K | 0 | SEC↗ |
| Hochberg Elaine | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| KLEIN JOSEPH III | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| Salzman Amber | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| Salzman Amber | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 53,000 | $0.21 | $11.1K | 0 | SEC↗ |
| SMITH SANDFORD D | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 52,837 | $5.94 | $313.9K | 0 | SEC↗ |
| SMITH SANDFORD D | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| YANG MICHAEL J. | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| Yanni Barbara | Director | D To issuer deriv | 2020-10-12 | 2020-10-13 | 26,400 | $2.01 | $53.1K | 0 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 120,000 | $5.39 | $646.8K | 0 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 200,000 | $5.39 | $1.08M | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 250,000 | $4.86 | $1.22M | 0 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 34,200 | $5.39 | $184.3K | 0 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 300,000 | $0.21 | $63.0K | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 143,374 | $5.94 | $851.6K | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 32,751 | $5.94 | $194.5K | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 13,701 | $0.77 | $10.5K | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 34,200 | $5.39 | $184.3K | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 299 | $0.77 | $230 | 0 | SEC↗ |
| Patterson Joshua F. | General Counsel | D To issuer deriv | 2020-10-12 | 2020-10-13 | 7,500 | $5.39 | $40.4K | 0 | SEC↗ |
| Patterson Joshua F. | General Counsel | D To issuer deriv | 2020-10-12 | 2020-10-13 | 13,750 | $1.16 | $15.9K | 0 | SEC↗ |
| PRICE MICHAEL DENNIS | Chief Financial Officer | D To issuer deriv | 2020-10-12 | 2020-10-13 | 300,000 | $3.37 | $1.01M | 0 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | U Tender | 2020-10-12 | 2020-10-13 | 242,978 | $18.15 | $4.41M | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | U Tender | 2020-10-12 | 2020-10-13 | 37,500 | $18.15 | $680.6K | 0 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | U Tender | 2020-10-12 | 2020-10-13 | 66,800 | $18.15 | $1.21M | 0 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | U Tender | 2020-10-12 | 2020-10-13 | 52,012 | $18.15 | $944.0K | 0 | SEC↗ |
| Patterson Joshua F. | General Counsel | U Tender | 2020-10-12 | 2020-10-13 | 26,532 | $18.15 | $481.6K | 0 | SEC↗ |
| PRICE MICHAEL DENNIS | Chief Financial Officer | U Tender | 2020-10-12 | 2020-10-13 | 50,000 | $18.15 | $907.5K | 0 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | P Buy | 2020-10-10 | 2020-10-14 | 21,237,715 | $18.15 | $385.46M | 98,322,397 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | S Sale | 2020-09-22 | 2020-09-24 | 8,709 | $18.12 | $157.8K | 242,978 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | S Sale | 2020-09-22 | 2020-09-24 | 720 | $18.12 | $13.0K | 52,012 | SEC↗ |
| Patterson Joshua F. | General Counsel | S Sale | 2020-09-22 | 2020-09-24 | 319 | $18.12 | $5.8K | 26,532 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award | 2020-08-31 | 2020-09-02 | 1,104 | $14.40 | $15.9K | 251,687 | SEC↗ |
| Patterson Joshua F. | General Counsel | S Sale | 2020-07-17 | 2020-07-20 | 263 | $12.50 | $3.3K | 26,851 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2020-07-09 | 2020-07-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award | 2020-07-09 | 2020-07-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PRICE MICHAEL DENNIS | Chief Financial Officer | A Award deriv | 2020-05-18 | 2020-05-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PRICE MICHAEL DENNIS | Chief Financial Officer | A Award | 2020-05-18 | 2020-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Patterson Joshua F. | General Counsel | A Award | 2020-04-15 | 2020-04-15 | 12,500 | — | $0 | 27,114 | SEC↗ |
| KLEIN JOSEPH III | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Hochberg Elaine | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Yanni Barbara | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| YANG MICHAEL J. | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| SMITH SANDFORD D | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Salzman Amber | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 26,400 | — | $0 | 26,400 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | S Sale | 2020-03-23 | 2020-03-25 | 9,417 | $11.75 | $110.6K | 245,783 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | S Sale | 2020-03-23 | 2020-03-25 | 3,198 | $11.75 | $37.6K | 61,602 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | S Sale | 2020-03-23 | 2020-03-25 | 779 | $11.75 | $9.2K | 52,732 | SEC↗ |
| Patterson Joshua F. | General Counsel | S Sale | 2020-03-23 | 2020-03-25 | 335 | $11.76 | $3.9K | 14,614 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award deriv | 2020-03-19 | 2020-03-23 | 109,800 | — | $0 | 109,800 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award deriv | 2020-03-19 | 2020-03-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Patterson Joshua F. | General Counsel | A Award deriv | 2020-03-19 | 2020-03-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award deriv | 2020-03-19 | 2020-03-23 | 34,200 | — | $0 | 34,200 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | A Award deriv | 2020-03-19 | 2020-03-23 | 34,200 | — | $0 | 34,200 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | A Award deriv | 2020-03-19 | 2020-03-23 | 34,200 | — | $0 | 34,200 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award deriv | 2020-03-19 | 2020-03-31 | 120,000 | — | $0 | 120,000 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award | 2020-03-19 | 2020-03-23 | 55,200 | — | $0 | 255,200 | SEC↗ |
| Patterson Joshua F. | General Counsel | A Award | 2020-03-19 | 2020-03-23 | 3,780 | — | $0 | 14,949 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award | 2020-03-19 | 2020-03-23 | 16,800 | — | $0 | 64,800 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | A Award | 2020-03-19 | 2020-03-23 | 16,800 | — | $0 | 53,511 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | A Award | 2020-03-19 | 2020-03-23 | 16,800 | — | $0 | 66,800 | SEC↗ |
| McDevitt Damien | Chief Executive Officer | A Award | 2020-03-19 | 2020-03-31 | 60,000 | — | $0 | 260,000 | SEC↗ |
| Salzman Amber | Director | A Award deriv | 2020-02-12 | 2020-02-13 | 53,000 | — | $0 | 53,000 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award | 2020-01-15 | 2020-01-16 | 28,000 | — | $0 | 48,000 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award | 2020-01-15 | 2020-01-16 | 28,000 | — | $0 | 48,000 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award deriv | 2020-01-02 | 2020-01-03 | 57,000 | — | $0 | 57,000 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award deriv | 2020-01-02 | 2020-01-03 | 57,000 | — | $0 | 57,000 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2019-12-17 | 2019-12-19 | 6,873,344 | — | $0 | 77,094,682 | SEC↗ |
| Yanni Barbara | Director | A Award deriv | 2019-12-13 | 2019-12-16 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | A Award deriv | 2019-12-02 | 2019-12-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Howarth Alex G. | Chief Operating Officer | A Award | 2019-12-02 | 2019-12-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | A Award deriv | 2019-10-21 | 2019-10-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Jenne Kyle | Chief Commercial Officer | A Award | 2019-10-21 | 2019-10-23 | 25,000 | — | $0 | 36,711 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 1,711,079 | — | $0 | 0 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 145,303 | — | $0 | 13,209 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 205,479 | — | $0 | 102,740 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 302,250 | — | $0 | 0 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 83,952 | — | $0 | 7,633 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise deriv | 2019-09-26 | 2019-09-30 | 35,230 | — | $0 | 17,607 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 1,113,492 | $16.64 | $18.53M | 597,587 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 175,064 | $16.64 | $2.91M | 678,149 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-09-26 | 2019-09-30 | 205,479 | $12.21 | $2.51M | 853,213 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 95,156 | $16.64 | $1.58M | 647,734 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-09-26 | 2019-09-30 | 145,303 | $6.48 | $941.6K | 742,890 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-09-26 | 2019-09-30 | 1,711,079 | $6.48 | $11.09M | 1,711,079 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise | 2019-09-26 | 2019-09-30 | 83,952 | $6.48 | $544.0K | 204,390 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 52,973 | $16.64 | $881.5K | 151,417 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 185,122 | $16.64 | $3.08M | 120,438 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise | 2019-09-26 | 2019-09-30 | 302,250 | $6.48 | $1.96M | 305,560 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise | 2019-09-26 | 2019-09-30 | 35,230 | $12.21 | $430.2K | 186,647 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | F Tax w/h | 2019-09-26 | 2019-09-30 | 30,016 | $16.64 | $499.5K | 156,631 | SEC↗ |
| KLEIN JOSEPH III | Director | A Award deriv | 2019-09-20 | 2019-09-23 | 53,000 | — | $0 | 53,000 | SEC↗ |
| YANG MICHAEL J. | Director | A Award deriv | 2019-09-20 | 2019-09-23 | 53,000 | — | $0 | 53,000 | SEC↗ |
| McDevitt Damien | Interim Chief Executive Offi | A Award deriv | 2019-09-19 | 2019-09-23 | 400,000 | — | $0 | 400,000 | SEC↗ |
| McDevitt Damien | Interim Chief Executive Offi | A Award | 2019-09-19 | 2019-09-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award | 2019-09-19 | 2019-09-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award | 2019-09-19 | 2019-09-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Boyce Sarah | President | S Sale | 2019-07-15 | 2019-07-17 | 1,819 | $23.52 | $42.8K | 19,888 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | A Award | 2019-07-01 | 2019-07-03 | 430 | $20.04 | $8.6K | 3,310 | SEC↗ |
| Boyce Sarah | President | A Award | 2019-07-01 | 2019-07-03 | 813 | $20.04 | $16.3K | 21,707 | SEC↗ |
| GABRIELI CHRISTOPHER | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| FITZGERALD EDWARD M | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| SMITH SANDFORD D | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Hochberg Elaine | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| MOSCICKI RICHARD A | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-04-08 | 2019-04-09 | 1,787 | — | $0 | 1,711,079 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise deriv | 2019-04-08 | 2019-04-09 | 20,000 | — | $0 | 302,250 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-04-08 | 2019-04-09 | 1,787 | $6.48 | $11.6K | 1,787 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | S Sale | 2019-04-08 | 2019-04-09 | 1,787 | $32.17 | $57.5K | 0 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise | 2019-04-08 | 2019-04-09 | 20,000 | $6.48 | $129.6K | 22,880 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | S Sale | 2019-04-08 | 2019-04-09 | 20,000 | $31.72 | $634.4K | 2,880 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-04-05 | 2019-04-09 | 30,000 | — | $0 | 1,712,866 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise deriv | 2019-04-05 | 2019-04-09 | 30,000 | — | $0 | 322,250 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-04-05 | 2019-04-09 | 30,000 | $6.48 | $194.4K | 30,000 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | S Sale | 2019-04-05 | 2019-04-09 | 30,000 | $32.11 | $963.3K | 0 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | S Sale | 2019-04-05 | 2019-04-09 | 30,000 | $31.71 | $951.3K | 2,880 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | M Exercise | 2019-04-05 | 2019-04-09 | 30,000 | $6.48 | $194.4K | 32,880 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2019-03-29 | 2019-04-02 | 2,837,373 | — | $0 | 70,221,338 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise deriv | 2019-03-06 | 2019-03-07 | 18,386 | — | $0 | 1,742,866 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | M Exercise | 2019-03-06 | 2019-03-07 | 18,386 | $6.48 | $119.1K | 18,386 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | S Sale | 2019-03-06 | 2019-03-07 | 18,386 | $32.14 | $590.9K | 0 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award deriv | 2019-01-02 | 2019-01-04 | 83,000 | — | $0 | 83,000 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award deriv | 2019-01-02 | 2019-01-04 | 83,000 | — | $0 | 83,000 | SEC↗ |
| Boyce Sarah | President | A Award deriv | 2019-01-02 | 2019-01-04 | 173,000 | — | $0 | 173,000 | SEC↗ |
| Soteropoulos Paula | Chief Executive Officer | A Award deriv | 2019-01-02 | 2019-01-04 | 296,000 | — | $0 | 296,000 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | A Award deriv | 2019-01-02 | 2019-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | J Other | 2019-01-01 | 2019-01-04 | 493 | $21.51 | $10.6K | 2,880 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2018-10-17 | 2018-10-18 | 1,671,849 | — | $0 | 67,383,965 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2018-08-03 | 2018-08-06 | 1,597,571 | — | $0 | 65,712,116 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | J Other | 2018-07-01 | 2018-07-02 | 1,398 | $14.77 | $20.6K | 2,387 | SEC↗ |
| MOSCICKI RICHARD A | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| MOSCICKI RICHARD A | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 26,400 | — | $0 | 26,400 | SEC↗ |
| FITZGERALD EDWARD M | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 26,400 | — | $0 | 26,400 | SEC↗ |
| SMITH SANDFORD D | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Hochberg Elaine | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 26,400 | — | $0 | 26,400 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 26,400 | — | $0 | 26,400 | SEC↗ |
| GABRIELI CHRISTOPHER | Director | A Award deriv | 2018-06-01 | 2018-06-28 | 26,400 | — | $0 | 26,400 | SEC↗ |
| PARSHALL B LYNNE | Director | A Award deriv | 2018-05-07 | 2018-05-08 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | A Award deriv | 2018-04-17 | 2018-04-17 | 320,000 | — | $0 | 320,000 | SEC↗ |
| Boyce Sarah | President | A Award deriv | 2018-04-17 | 2018-04-18 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Boyce Sarah | President | A Award | 2018-04-17 | 2018-04-18 | 20,894 | — | $0 | 20,894 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | P Buy | 2018-04-17 | 2018-04-19 | 10,666,666 | $18.75 | $200.00M | 64,114,545 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2018-04-17 | 2018-04-19 | 8,000,000 | — | $0 | 53,447,879 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award deriv | 2018-01-02 | 2018-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| O'Dea Louis | Chief Medical Officer | A Award deriv | 2018-01-02 | 2018-01-04 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | A Award deriv | 2018-01-02 | 2018-01-04 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Soteropoulos Paula | President & CEO | A Award deriv | 2018-01-02 | 2018-01-04 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Goldberg Jeff Marc | Chief Operating Officer | J Other | 2018-01-01 | 2018-01-04 | 989 | $6.80 | $6.7K | 989 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award deriv | 2017-08-31 | 2017-09-05 | 332,708 | — | $0 | 332,708 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | C Conversion deriv | 2017-07-19 | 2017-07-21 | 28,884,540 | — | $0 | 0 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | C Conversion | 2017-07-19 | 2017-07-21 | 28,884,540 | — | $0 | 28,884,540 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | J Other | 2017-07-19 | 2017-07-21 | 13,438,339 | — | $0 | 42,322,879 | SEC↗ |
| IONIS PHARMACEUTICALS INC | 10% Owner | P Buy | 2017-07-19 | 2017-07-21 | 3,125,000 | $8.00 | $25.00M | 45,447,879 | SEC↗ |